Rivalry, Strategic Groups and Firm Profitability

An analysis of the U.S. pharmaceutical industry during the period 1963–82 finds that a substantial decline in industry profitability is not explained by changes in the number and size distribution of firms, in segment interdependence and in strategic distance. In contrast, declining industry profitability is strongly associated with increasing rivalry. This increasing rivalry is associated with changes in strategic group structure and a concomitant shift from within group rivalry to between group rivalry.

[1]  A. Zellner.  An Efficient Method of Estimating Seemingly Unrelated Regressions and Tests for Aggregation Bias , 1962 .

[2]  P. E. Hart.  Entropy and Other Measures of Concentration , 1971 .

[3]  W. G. Shepherd,et al.  The Elements of Market Structure , 1972 .

[4]  Michael Hunt.  Competition in the major home appliance industry, 1960-1970 , 1972 .

[5]  D. Schendel,et al.  Heterogeneity within an Industry: Firm Conduct in the U.S. Brewing Industry, 1952-71 , 1977 .

[6]  M. Porter,et al.  From Entry Barriers to Mobility Barriers: Conjectural Decisions and Contrived Deterrence to New Competition , 1977 .

[7]  D. Schendel,et al.  A Simultaneous Equation Model of Corporate Strategy , 1978 .

[8]  H. H. Newman.  Strategic Groups and the Structure-Performance Relationship , 1978 .

[9]  John Kwoka.  The Effect of Market Share Distribution on Industry Performance: Reply , 1979 .

[10]  H. H. Newman.  Strategic groups and the structure-performance relationship : a study with respect to the chemical process industries , 1979 .

[11]  M. Porter.  The Structure Within Industries and Companies' Performance , 1979 .

[12]  R. Caves,et al.  Economic Analysis and the Quest for Competitive Advantage , 1984 .

[13]  Michael Waterson,et al.  Economic theory of the industry , 1984 .

[14]  W. S. Comanor,et al.  The political economy of the pharmaceutical industry. , 1986, Journal of economic literature.

[15]  H. Thomas,et al.  Strategic Groups: Theory, Research and Taxonomy , 1986 .

[16]  D. Ravenscraft,et al.  Cooperation vs.Rivalry: Price-Cost Margins by Line of Business , 1986 .

[17]  Richard Schmalensee,et al.  Inter-industry studies of structure and performance , 1987 .

[18]  Mary Louise Hatten,et al.  Strategic groups, asymmetrical mobility barriers and contestability , 1987 .

[19]  Karel Cool,et al.  Strategic Group Formation and Performance: The Case of the U.S. Pharmaceutical Industry, 1963-1982 , 1987 .

[20]  Richard E. Caves,et al.  Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals , 1988, The Journal of Law and Economics.

[21]  Michael Hergert,et al.  Causes and Consequences of Strategic Grouping in U. S. Manufacturing Industries , 1988 .

[22]  Research notes and communications strategic groups: A comment , 1989 .

[23]  Donald D. Bergh,et al.  Performance Variations Among Strategic Group Members: An Examination of Individual Firm Capability , 1989 .

[24]  D. Aaker,et al.  Mobility barriers and strategic groups , 1989 .

[25]  H. Thomas,et al.  STRATEGIC GROUPS AND PERFORMANCE: THE U.S. INSURANCE INDUSTRY, 1970-84 , 1990 .

[26]  Henry G. Grabowski,et al.  A New Look at the Returns and Risks to Pharmaceutical R&D , 1990 .

[27]  L. G. Thomas.  Regulation and Firm Size: FDA Impacts on Innovation , 1990 .